Works matching DE "NATALIZUMAB"


Results: 1783
    1

    Oral Colonization by Candida Species in Patients with Multiple Sclerosis.

    Published in:
    Mycopathologia, 2020, v. 185, n. 6, p. 983, doi. 10.1007/s11046-020-00486-1
    By:
    • da Cunha, Eliana Tomomi Shimabukuro;
    • Figueiredo-Godoi, Lívia Mara Alves;
    • Santos, Diogo Haddad;
    • Carneiro, Rafael Paterno Castello Dias;
    • do Olival, Guilherme Sciascia;
    • de Barros, Patrícia Pimentel;
    • Narimatsu, Keila;
    • Tilbery, Charles Peter;
    • Junqueira, Juliana Campos
    Publication type:
    Article
    2

    Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.

    Published in:
    2021
    By:
    • Alleg, Manel;
    • Solis, Morgane;
    • Baloglu, Seyyid;
    • Cotton, François;
    • Kerschen, Philippe;
    • Bourre, Bertrand;
    • Ahle, Guido;
    • Pruvo, Jean-Pierre;
    • Leclerc, Xavier;
    • Vermersch, Patrick;
    • Papeix, Caroline;
    • Maillart, Élisabeth;
    • Houillier, Caroline;
    • Chabrot, Cécile Moluçon;
    • Claise, Béatrice;
    • Malak, Sandra;
    • Martin-Blondel, Guillaume;
    • Bonneville, Fabrice;
    • Caulier, Alexis;
    • Marolleau, Jean-Pierre
    Publication type:
    journal article
    3
    4
    5

    Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Family Planning within the Management of MS.

    Published in:
    Clinical & Translational Neuroscience, 2023, v. 7, n. 2, p. 1, doi. 10.3390/ctn7020010
    By:
    • Al-Khawajah, Mona M.;
    • Al-Barakati, Rayan G.;
    • Al-Jedai, Ahmed H.;
    • Al-Malik, Yaser M.;
    • Al-Mudaiheem, Hajer Y.;
    • Al-Omari, Bedor A.;
    • Al-Thubaiti, Ibtisam A.;
    • Al-Yafeai, Rumaiza H.;
    • Bunyan, Reem F.;
    • Cupler, Edward J.;
    • Hakami, Mohammed;
    • Kedah, Hanaa M.;
    • Makkawi, Seraj;
    • Saeed, Leena H.;
    • Saeedi, Jameelah A.;
    • Shosha, Eslam;
    • Al-Jumah, Mohammed A.
    Publication type:
    Article
    6
    7
    8
    9

    Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 13, p. 3584, doi. 10.3390/jcm11133584
    By:
    • Hernández-Preciado, Martha Rocio;
    • Marquez-Pedroza, Jazmin;
    • Sánchez-Rosales, Nayeli Alejandra;
    • García-Rivera, José de Jesús;
    • Kobayashi-Gutiérrez, Antonio;
    • Torres-Mendoza, Blanca Miriam;
    • Chavarría-Avila, Efraín;
    • Montaño-Serrano, Raúl Alejandro;
    • Cortes-Enriquez, Fernando;
    • Mireles-Ramírez, Mario Alberto
    Publication type:
    Article
    10

    Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1830, doi. 10.3390/jcm10091830
    By:
    • Jamroz-Wiśniewska, Anna;
    • Zajdel, Radosław;
    • Słowik, Agnieszka;
    • Marona, Monika;
    • Wnuk, Marcin;
    • Adamczyk-Sowa, Monika;
    • Adamczyk, Bożena;
    • Lasek-Bal, Anetta;
    • Puz, Przemysław;
    • Stęposz, Arkadiusz;
    • Krzystanek, Ewa;
    • Patalong-Ogiewa, Maja;
    • Pokryszko-Dragan, Anna;
    • Budrewicz, Sławomir;
    • Koziarska, Dorota;
    • Karbicka, Anna;
    • Wawrzyniak, Sławomir;
    • Fryze, Waldemar;
    • Furtak-Niczyporuk, Marzena;
    • Rejdak, Konrad
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18

    Anti-John Cunningham Virus antibody prevalence in multiple sclerosis patients in Turkey.

    Published in:
    Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2014, v. 31, n. 1, p. 31, doi. 10.5835/jecm.omu.31.01.006
    By:
    • Eraksoy, Mefkure;
    • Agan, Kadriye;
    • Ak, Fikri;
    • Anlar, Omer;
    • Balci, Belgin Petek;
    • Boz, Cavit;
    • Celik, Yahya;
    • Demirkaya, Seref;
    • Efendi, Husnu;
    • Gedizlioglu, Muhtesem;
    • Gunal, Dilek;
    • Gungor, Hulya Aydin;
    • Isik, Nihal;
    • Idiman, Egemen;
    • Karabudak, Rana;
    • Kurne, Asli;
    • Neyal, Munife;
    • Ozakbas, Serkan;
    • Ozbay, Ozgul Ekmekci;
    • Ozcanq, Cemal
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis.

    Published in:
    Cardiogenetics, 2022, v. 12, n. 2, p. 133, doi. 10.3390/cardiogenetics12020014
    By:
    • Lioncino, Michele;
    • Monda, Emanuele;
    • Dellegrottaglie, Santo;
    • Cirillo, Annapaola;
    • Caiazza, Martina;
    • Fusco, Adelaide;
    • Esposito, Francesca;
    • Verrillo, Federica;
    • Ciccarell, Giovanni;
    • Rubino, Marta;
    • Triggiani, Massimo;
    • Scarpa, Raffaele;
    • Caforio, Alida Linda Patrizia;
    • Marcolongo, Renzo;
    • Rizzo, Stefania;
    • Basso, Cristina;
    • Nigro, Gerardo;
    • Russo, Maria Giovanna;
    • Golino, Paolo;
    • Limongelli, Giuseppe
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center.

    Published in:
    Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.699844
    By:
    • Boziki, Marina;
    • Bakirtzis, Christos;
    • Giantzi, Virginia;
    • Sintila, Styliani-Aggeliki;
    • Kallivoulos, Stylianos;
    • Afrantou, Theodora;
    • Nikolaidis, Ioannis;
    • Ioannidis, Panagiotis;
    • Karapanayiotides, Theodoros;
    • Koutroulou, Ioanna;
    • Parissis, Dimitrios;
    • Grigoriadis, Nikolaos
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

    Published in:
    Multiple Sclerosis International, 2016, p. 1, doi. 10.1155/2016/1034912
    By:
    • Alroughani, Raed;
    • Altintas, Ayse;
    • Al Jumah, Mohammed;
    • Sahraian, Mohammadali;
    • Alsharoqi, Issa;
    • AlTahan, Abdurahman;
    • Daif, Abdulkader;
    • Dahdaleh, Maurice;
    • Deleu, Dirk;
    • Fernandez, Oscar;
    • Grigoriadis, Nikolaos;
    • Inshasi, Jihad;
    • Karabudak, Rana;
    • Taha, Karim;
    • Totolyan, Natalia;
    • Yamout, Bassem I.;
    • Zakaria, Magd;
    • Boholega, Saeed
    Publication type:
    Article
    50